Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aryan Shekarabi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pharmacological Reviews|June 15, 2023
Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic DevelopmentsJames E Barrett, Aryan Shekarabi, Saadet Inan
Physiology & Behavior|July 29, 2022
Energy drink produces aversive effects in planariansPrateek Mokkarala, Aryan Shekarabi, Sonita Wiah, et al.
Current Opinion in Microbiology|June 2, 2024
Host-microbe interactions: communication in the microbiota-gut-brain axisAryan Shekarabi, Izhan Qureishy, Chloe H Puglisi, et al.
Brain Research|March 5, 2023
Cyanidin prevents MDPV withdrawal-induced anxiety-like effects and dysregulation of cytokine systems in ratsSaadet Inan, Joseph J Meissler, Aryan Shekarabi, et al.
Physiology & Behavior|July 25, 2024
Clavulanic acid inhibits methamphetamine locomotor sensitization in mice and normalizes methamphetamine-induced changes in glutaminase mRNA levels in the nucleus accumbensTaylor Hawthorne Walters, Sonita Wiah, Aryan Shekarabi, et al.
Drug and Alcohol Dependence|December 15, 2022
Troriluzole inhibits methamphetamine place preference in rats and normalizes methamphetamine-evoked glutamate carboxypeptidase II (GCPII) protein levels in the mesolimbic pathwaySonita Wiah, Abigail Roper, Pingwei Zhao, et al.
Brain, Behavior, and Immunity|September 29, 2022
Purinergic P2X7 receptor antagonist inhibits methamphetamine-induced reward, hyperlocomotion, and cortical IL-7A levels in mice: A role for P2X7/IL-17A crosstalk in methamphetamine behaviors?Raghava Potula, Taylor A Gentile, Joseph J Meissler, et al.
Drug and Alcohol Dependence|July 17, 2022
Multi-chemokine receptor antagonist RAP-103 inhibits opioid-derived respiratory depression, reduces opioid reinforcement and physical dependence, and normalizes opioid-induced dysregulation of mesolimbic chemokine receptors in ratsAngela R Bongiovanni, Pingwei Zhao, Saadet Inan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pharmacological Reviews|June 15, 2023
Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic DevelopmentsJames E Barrett, Aryan Shekarabi, Saadet Inan
Physiology & Behavior|July 29, 2022
Energy drink produces aversive effects in planariansPrateek Mokkarala, Aryan Shekarabi, Sonita Wiah, et al.
Current Opinion in Microbiology|June 2, 2024
Host-microbe interactions: communication in the microbiota-gut-brain axisAryan Shekarabi, Izhan Qureishy, Chloe H Puglisi, et al.
Brain Research|March 5, 2023
Cyanidin prevents MDPV withdrawal-induced anxiety-like effects and dysregulation of cytokine systems in ratsSaadet Inan, Joseph J Meissler, Aryan Shekarabi, et al.
Physiology & Behavior|July 25, 2024
Clavulanic acid inhibits methamphetamine locomotor sensitization in mice and normalizes methamphetamine-induced changes in glutaminase mRNA levels in the nucleus accumbensTaylor Hawthorne Walters, Sonita Wiah, Aryan Shekarabi, et al.
Drug and Alcohol Dependence|December 15, 2022
Troriluzole inhibits methamphetamine place preference in rats and normalizes methamphetamine-evoked glutamate carboxypeptidase II (GCPII) protein levels in the mesolimbic pathwaySonita Wiah, Abigail Roper, Pingwei Zhao, et al.
Brain, Behavior, and Immunity|September 29, 2022
Purinergic P2X7 receptor antagonist inhibits methamphetamine-induced reward, hyperlocomotion, and cortical IL-7A levels in mice: A role for P2X7/IL-17A crosstalk in methamphetamine behaviors?Raghava Potula, Taylor A Gentile, Joseph J Meissler, et al.
Drug and Alcohol Dependence|July 17, 2022
Multi-chemokine receptor antagonist RAP-103 inhibits opioid-derived respiratory depression, reduces opioid reinforcement and physical dependence, and normalizes opioid-induced dysregulation of mesolimbic chemokine receptors in ratsAngela R Bongiovanni, Pingwei Zhao, Saadet Inan, et al.
Pageof 1